The FDA Wants to Talk Psychedelic Therapy. The Movement Has Bigger Questions.
A federal docket on the therapeutic use of psychedelics is open through October 5. Four groups that built this movement from the ground up on what they’d tell the government, what they’re fighting in court, and how much of their work the docket doesn’t cover. The Food and Drug Administration held a public hearing on […]
The FDA Wants to Know How You Use Cannabis—Useful or Concerning?
The FDA is seeking outside data and analytics services to better understand how people use cannabis, CBD, and other emerging products through public social-media conversations, consumer surveys, and market intelligence. The request does not establish access to private messages, but it does point to a much more systematic federal effort to analyze how cannabis consumers […]